Articles about 'Cambridge Infectious Diseases'

As countries adopt different approaches, the question remains: how best to enact a lockdown without compromising critical food supply chains in the short and longer term?

On 22nd March 2020, Cambridge University Botanic Garden closed its gates to protect visitors and staff during the global coronavirus pandemic. Coinciding almost exactly with the start of Spring, this felt like a particularly cruel blow. 

A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.

Over the past 70 years richer nations have gradually lost their sense of danger concerning epidemics and serious infections, writes Professor Gordon Dougan. We must now reacquire this instinctive memory.

A new multinational study has shown how the process of distinguishing viruses and bacteria could be accelerated through the use of computational methods.

The University of Cambridge is to take a leading role in a major national effort to help understand and control the new coronavirus infection (COVID-19) announced today by the Government and the UK’s Chief Scientific Adviser.

Writing for The Conversation, Edward Emmott, Research Associate in Virology explores why this notorious virus can cause the NHS such difficulty.

Some of the final cases of Ebola in Sierra Leone were transmitted via unconventional routes, such as semen and breastmilk, according to the largest analysis to date of the tail-end of the epidemic.

A rise in the number of outbreaks of vaccine-preventable diseases has highlighted the growing trend for parents not to have their child vaccinated. Could the activities of a group of teenagers in 1950s America inspire a fresh look at the effectiveness of pro-vaccine public health information campaigns?

Samples from the recently confirmed case of Ebola in Sierra Leone have been analysed at a new infectious diseases laboratory in the country, set up in partnership with the University of Cambridge in the wake of the epidemic.